Open-End Investment Fund
Fonte Health Sciences Fund OEIC Limited
Investing in the Future of Medicine
The Fund finances innovative healthcare projects and biomedical technologies, supporting medical research, novel therapies, and healthcare infrastructure modernization. We invest in pharmaceutical developers, medical equipment producers, and healthcare providers with transformative potential, focusing on innovations that improve patient outcomes while delivering sustainable returns
USD
Investment Currency
1 USD
Nominal Unit Price
From 10%
Target Return
Privileges of Unit Holders
After purchasing units, considering the Fund's unlimited or long-term investment horizon, a Lock-up period of 180 days is established for each Unit Holder
1
Exemption from capital gains tax on the appreciation and sale of shares and securities listed on the stock exchange at the time of sale
2
Exemption from taxes on dividends received from securities listed on the official stock exchange at the time they are declared
3
Provision of the ability to purchase and redeem units in various currencies
Asset Allocation
The Fund will predominantly invest in fixed-income securities with no preference to maturities, corporate debt securities of Emerging Markets, Eurobonds.
87%
Cash and Cash equivalents
13%
Others
Fund Characteristics
-
Suitable for
Qualified Investors
-
Minimum Investment
$50,000
-
Subscription Frequency
Daily
-
Management Fee
2%
-
Performance Fee
20%
-
Operational Fees
Up to 2%